201. Apoptosis induced by desmethyl-lasiodiplodin is associated with upregulation of apoptotic genes and downregulation of monocyte chemotactic protein-3.
- Author
-
Hazalin NA, Lim SM, Cole AL, Majeed AB, and Ramasamy K
- Subjects
- Animals, Antineoplastic Agents isolation & purification, Antineoplastic Agents toxicity, Apoptosis genetics, Apoptosis Regulatory Proteins genetics, Breast Neoplasms genetics, Breast Neoplasms metabolism, Caspase 3 genetics, Caspase 3 metabolism, Cell Proliferation drug effects, Chemokine CCL7 genetics, Chromatography, Liquid, Dose-Response Relationship, Drug, Down-Regulation, Endophytes chemistry, Female, Humans, Inhibitory Concentration 50, MCF-7 Cells, Magnetic Resonance Spectroscopy, Mass Spectrometry, Mice, Mycotoxins isolation & purification, Mycotoxins toxicity, Proto-Oncogene Proteins c-myc genetics, Proto-Oncogene Proteins c-myc metabolism, Spectrophotometry, Ultraviolet, Tumor Suppressor Protein p53 genetics, Tumor Suppressor Protein p53 metabolism, Up-Regulation, Zearalenone isolation & purification, Zearalenone pharmacology, Zearalenone toxicity, Antineoplastic Agents pharmacology, Apoptosis drug effects, Apoptosis Regulatory Proteins metabolism, Breast Neoplasms pathology, Chemokine CCL7 metabolism, Mycotoxins pharmacology, Zearalenone analogs & derivatives
- Abstract
There is growing interest in the discovery of bioactive metabolites from endophytes as an alternative source of therapeutics. Identification of their therapeutic targets is essential in understanding the underlying mechanisms and enhancing the resultant therapeutic effects. As such, bioactive compounds produced by endophytic fungi from plants at the National Park, Pahang, Malaysia, were investigated. Five known compounds were identified using LC-UV-MS-NMR and they include trichodermol, 7-epi-brefeldin A, (3R,4S)-4-hydroxymellein, desmethyl-lasiodiplodin and cytochalasin D. The present study went on to investigate the potential anticancer effects of these compounds and the corresponding molecular mechanisms of the lead compound against human breast adenocarcinoma, MCF-7. For the preliminary screening, the cytotoxicity and apoptotic effects of these compounds against MCF-7 were examined. The compounds were also tested against noncarcinogenic hepatocytes (WRL68). The differential cytotoxicity was then determined using the MTT assay. Desmethyl-lasiodiplodin was found to suppress the growth of MCF-7, yielding an inhibitory concentration (IC50) that was seven-fold lower than that of the normal cells. The cytotoxic effect of desmethyl-lasiodiplodin was accompanied by apoptosis. Subsequent analysis demonstrated increased expression levels of caspase 3, c-myc and p53. Further, desmethyl-lasiodiplodin resulted in inhibition of monocyte chemotactic protein (MCP)-3, a cytokine involved in cell survival and metastasis. Hence, this study proposed that desmethyl-lasiodiplodin inhibited growth and survival of MCF-7 through the induction of apoptosis. This anticancer effect is mediated, in part, by upregulation of apoptotic genes and downregulation of MCP-3. As desmethyl-lasiodiplodin elicited minimal impact against normal hepatocytes, our findings also imply its potential use as a specific apoptotic agent in breast cancer treatment.
- Published
- 2013
- Full Text
- View/download PDF